Literature DB >> 9239633

Bilateral xanthine nephrolithiasis in a dog.

J Kucera1, T Bulková, R Rychlá, P Jahn.   

Abstract

Xanthinuria is an uncommon metabolic disorder clinically manifested as urolithiasis. There are two forms of the disease, congenital and iatrogenic. The former was diagnosed in a four-year-old dachshund bitch. The patient was presented with signs of terminal chronic renal failure. Urine was bacteriologically sterile with massive amorphous crystalluria. Bilateral nephrolithiasis was diagnosed at necropsy. The kidneys were shrunken with marked atrophy of the renal cortex and medulla. Infrared spectrometry revealed that the stones comprised 100 per cent xanthine. Later, two of the patient's siblings were examined for urine xanthine content; both showed higher concentrations of xanthine than a control dog. The described case is compared with seven known published cases of congenital xanthinuria.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9239633     DOI: 10.1111/j.1748-5827.1997.tb03471.x

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  9 in total

1.  Hereditary xanthinuria and urolithiasis in a domestic shorthair cat.

Authors:  E Furman; E H Hooijberg; E Leidinger; C Zedinger; U Giger; J Leidinger
Journal:  Comp Clin Path       Date:  2015-01-30

2.  Hereditary xanthinuria in a goat.

Authors:  Krystal J Vail; Nicole M Tate; Tasha Likavec; Katie M Minor; Philippa M Gibbons; Raquel R Rech; Eva Furrow
Journal:  J Vet Intern Med       Date:  2019-02-13       Impact factor: 3.333

Review 3.  Inherited metabolic disease in companion animals: searching for nature's mistakes.

Authors:  Adrian C Sewell; Mark E Haskins; Urs Giger
Journal:  Vet J       Date:  2006-11-07       Impact factor: 2.688

4.  Canine urolithiasis: a look at over 16 000 urolith submissions to the Canadian Veterinary Urolith Centre from February 1998 to April 2003.

Authors:  Doreen M Houston; Andrew E P Moore; Michael G Favrin; Brent Hoff
Journal:  Can Vet J       Date:  2004-03       Impact factor: 1.008

Review 5.  Mechanistic insights into xanthine oxidoreductase from development studies of candidate drugs to treat hyperuricemia and gout.

Authors:  Takeshi Nishino; Ken Okamoto
Journal:  J Biol Inorg Chem       Date:  2014-12-12       Impact factor: 3.358

6.  The renal phenotype of allopurinol-treated HPRT-deficient mouse.

Authors:  Cristina Zennaro; Federica Tonon; Paola Zarattini; Milan Clai; Alessandro Corbelli; Michele Carraro; Marialaura Marchetti; Luca Ronda; Gianluca Paredi; Maria Pia Rastaldi; Riccardo Percudani
Journal:  PLoS One       Date:  2017-03-10       Impact factor: 3.240

Review 7.  Mutations associated with functional disorder of xanthine oxidoreductase and hereditary xanthinuria in humans.

Authors:  Kimiyoshi Ichida; Yoshihiro Amaya; Ken Okamoto; Takeshi Nishino
Journal:  Int J Mol Sci       Date:  2012-11-21       Impact factor: 5.923

Review 8.  Animal models of naturally occurring stone disease.

Authors:  Ashley Alford; Eva Furrow; Michael Borofsky; Jody Lulich
Journal:  Nat Rev Urol       Date:  2020-11-06       Impact factor: 16.430

9.  Multiple variants in XDH and MOCOS underlie xanthine urolithiasis in dogs.

Authors:  Nicole M Tate; Katie M Minor; Jody P Lulich; James R Mickelson; Allyson Berent; Jonathan D Foster; Kasey H Petersen; Eva Furrow
Journal:  Mol Genet Metab Rep       Date:  2021-09-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.